Qualigen Therapeutics, Inc.
USD3.21
+0.17 (+5.59%)
CEO
Kevin A. Richardson II
IPO Date
2015-06-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.98
Prev. Close
$3.04
Day Low
$2.86
Day High
$3.34
52W Low
$1.61
52W High
$8.81
Market Cap
$0.01B
Volume
0.37M
| 40,000 |
| $0.51 |
| 4 Aug 2022 | Poirier Michael S. | Chairman and CEO | A-Award | Acquired | 375,000 | $0.00 |
| 4 Aug 2022 | Lotz Christopher L. | Vice President of Finance, CFO | A-Award | Acquired | 100,000 | $0.00 |
| 4 Aug 2022 | Lotz Christopher L. | Vice President of Finance, CFO | A-Award | Acquired | 100,000 | $0.51 |
| 4 Aug 2022 | Sinha Shishir K. | VP, COO & Secretary | A-Award | Acquired | 100,000 | $0.00 |
| 4 Aug 2022 | Sinha Shishir K. | VP, COO & Secretary | A-Award | Acquired | 100,000 | $0.51 |
| 4 Aug 2022 | David Richard A. | director: | A-Award | Acquired | 40,000 | $0.00 |
| 4 Aug 2022 | David Richard A. | director | A-Award | Acquired | 40,000 | $0.51 |
| 4 Aug 2022 | Abdul-Ahad Wajdi | Vice President, R & D, CSO | A-Award | Acquired | 80,000 | $0.00 |